dextroamphetamine has been researched along with Froehlich's Syndrome in 5 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A limited number of published case reports suggest a positive effect of dextroamphetamine, an adrenergic agonist affecting both the central nervous system (CNS) and peripheral nervous system, on physical activity and weight in patients with hypothalamic obesity (intractable obesity following CNS insult)." | 7.91 | Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series. ( Denzer, C; Denzer, F; Lennerz, BS; Lustig, RH; Vollbach, H; Wabitsch, M, 2019) |
| "A limited number of published case reports suggest a positive effect of dextroamphetamine, an adrenergic agonist affecting both the central nervous system (CNS) and peripheral nervous system, on physical activity and weight in patients with hypothalamic obesity (intractable obesity following CNS insult)." | 3.91 | Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series. ( Denzer, C; Denzer, F; Lennerz, BS; Lustig, RH; Vollbach, H; Wabitsch, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Schaik, J | 1 |
| Welling, MS | 1 |
| de Groot, CJ | 1 |
| van Eck, JP | 1 |
| Juriaans, A | 1 |
| Burghard, M | 1 |
| Oude Ophuis, SBJ | 1 |
| Bakker, B | 1 |
| Tissing, WJE | 1 |
| Schouten-van Meeteren, AYN | 1 |
| van den Akker, ELT | 1 |
| van Santen, HM | 1 |
| Denzer, C | 1 |
| Denzer, F | 1 |
| Lennerz, BS | 1 |
| Vollbach, H | 1 |
| Lustig, RH | 1 |
| Wabitsch, M | 1 |
| Ismail, D | 1 |
| O'Connell, MA | 1 |
| Zacharin, MR | 1 |
| Leshem, M | 1 |
| Stunkard, AJ | 1 |
1 review available for dextroamphetamine and Froehlich's Syndrome
| Article | Year |
|---|---|
Anorectic agents lower a body weight set point.
Topics: Animals; Appetite Depressants; Appetite Regulation; Behavior Therapy; Body Weight; Dextroamphetamine | 1982 |
4 other studies available for dextroamphetamine and Froehlich's Syndrome
| Article | Year |
|---|---|
Dextroamphetamine Treatment in Children With Hypothalamic Obesity.
Topics: Adolescent; Child; Dextroamphetamine; Energy Metabolism; Humans; Hypothalamic Diseases; Obesity; Ret | 2022 |
Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series.
Topics: Adolescent; Adult; Body Mass Index; Child; Cohort Studies; Dextroamphetamine; Exercise; Female; Heal | 2019 |
Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury.
Topics: Adolescent; Central Nervous System Stimulants; Child; Child, Preschool; Craniopharyngioma; Dextroamp | 2006 |
Morphine-induced anorexia in lateral hypothalamic rats.
Topics: Amphetamine; Animals; Anorexia; Dextroamphetamine; Feeding and Eating Disorders; Fenfluramine; Human | 1981 |